Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. World Health Organization. World alliance for patient safety: WHO draft guidelines for adverse event reporting and learning systems: from information to action. Geneva: World Health Organization; 2005.
2. McNeal TM, Colbert CY, Cable C, et al. Patients’ attention to and understanding of adverse drug reaction warnings. Patient Intell. 2010;2:59–68.
3. Shiyanbola OO, Farris KB, Urmie JM, et al. Risk factors of self-reported adverse drug events among Medicare enrollees before and after Medicare Part D. Pharm Pract (Granada). 2009;7:218–27.
4. Lee YH, Kang UG, Part RW. Development of adverse drug event surveillance system using BI technology. J Korea Contents Assoc. 2009;9:106–14.
5. Rodriguez-Monguior R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21:623–50.